chr12-50104771-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_005276.4(GPD1):c.219+20G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000695 in 1,604,806 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.00073 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00069 ( 5 hom. )
Consequence
GPD1
NM_005276.4 intron
NM_005276.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0600
Genes affected
GPD1 (HGNC:4455): (glycerol-3-phosphate dehydrogenase 1) This gene encodes a member of the NAD-dependent glycerol-3-phosphate dehydrogenase family. The encoded protein plays a critical role in carbohydrate and lipid metabolism by catalyzing the reversible conversion of dihydroxyacetone phosphate (DHAP) and reduced nicotine adenine dinucleotide (NADH) to glycerol-3-phosphate (G3P) and NAD+. The encoded cytosolic protein and mitochondrial glycerol-3-phosphate dehydrogenase also form a glycerol phosphate shuttle that facilitates the transfer of reducing equivalents from the cytosol to mitochondria. Mutations in this gene are a cause of transient infantile hypertriglyceridemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 12-50104771-G-A is Benign according to our data. Variant chr12-50104771-G-A is described in ClinVar as [Benign]. Clinvar id is 1606500.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr12-50104771-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000729 (111/152346) while in subpopulation NFE AF= 0.00146 (99/68030). AF 95% confidence interval is 0.00122. There are 0 homozygotes in gnomad4. There are 48 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPD1 | NM_005276.4 | c.219+20G>A | intron_variant | ENST00000301149.8 | NP_005267.2 | |||
GPD1 | NM_001257199.2 | c.219+20G>A | intron_variant | NP_001244128.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPD1 | ENST00000301149.8 | c.219+20G>A | intron_variant | 1 | NM_005276.4 | ENSP00000301149 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000729 AC: 111AN: 152228Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
111
AN:
152228
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000689 AC: 170AN: 246586Hom.: 1 AF XY: 0.000691 AC XY: 92AN XY: 133210
GnomAD3 exomes
AF:
AC:
170
AN:
246586
Hom.:
AF XY:
AC XY:
92
AN XY:
133210
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000692 AC: 1005AN: 1452460Hom.: 5 Cov.: 30 AF XY: 0.000778 AC XY: 562AN XY: 722430
GnomAD4 exome
AF:
AC:
1005
AN:
1452460
Hom.:
Cov.:
30
AF XY:
AC XY:
562
AN XY:
722430
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000729 AC: 111AN: 152346Hom.: 0 Cov.: 32 AF XY: 0.000644 AC XY: 48AN XY: 74492
GnomAD4 genome
AF:
AC:
111
AN:
152346
Hom.:
Cov.:
32
AF XY:
AC XY:
48
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at